When Chronic Skin Inflammation and Slow Resolving Wounds Need More Than Routine Care
VetEase offers a drug free and non-invasive approach for the cases that test client patience, consume team time, and are frustrating to manage
clinical Applications
Equine Wounds
Interdigital Lesions
Blepharitis
Chronic Allergic Dermatitis
Post Graft Care
Feline Wounds
Post Mastectomy Necrosis
Surgical Wound Management
Allergic Dermatitis with Hair Loss
Controlled Cooling
VetEase applies controlled cooling to the treatment site using rapid precision control technology informed by continuous real-time skin surface temperature monitoring. By rapidly lowering local tissue temperature, this cooling step is intended to help modulate inflammatory activity, reduce vasodilation and local metabolic demand, and support a more favorable treatment environment.
How VetEase Works
Targeted Delivery Mechanism
PIPD, or Picoliter Ice Particle Delivery, is VetEase’s needle-free delivery technology atomizes VexoHeal into micro-droplets of approximately 30 µm, flash-freezes them at 2°C into solid particles, and accelerates them toward the target site at approximately 300 km/h. This sequence occurs in approximately 300 microseconds and is designed to enable localized topical delivery while helping protect sensitive biologic components during processing.
VexoHeal
VexoHeal is VetEase’s lyophilized exosome-enriched topical skin serum. Exosomes are being studied for their role in intercellular signaling and support of tissue repair processes, making them of interest in cases involving inflammation, impaired skin recovery, and coat or barrier disruption.
VetEase combines two core elements in one treatment approach: the VetEase device platform and VexoHeal, its lyophilized exosome-enriched topical skin serum
VetEase atomizes VexoHeal into ~30 µm droplets, flash-freezes them at 2°C, and accelerates them toward the target site at approximately 300 km/h
Together, VetEase and VexoHeal are designed to help calm localized inflammation and support a favorable local treatment environment in difficult derm and wound cases
Outcomes
15-year-old neutered Westie presenting with recurrent paw skin lesions and severe pain-associated lameness. VetEase protocol was 4 treatments over 4 weeks.
2-year-old neutered female Poodle presenting with blepharitis with steroid contraindications. VetEase was applied 4 times over 4 weeks.
11-year-old spayed Maltese with hind limb lichenification and alopecia secondary to chronic allergic dermatitis. VetEase protocol was 6 total treatments over 6 weeks.
14 year old neutered beagle post right hind STS resection with graft. Developed graft inflammation, and pigment changes. Dog received 6 VetEase sessions over 3 weeks
Senior cat suffered a traumatic soft tissue wound. Underlying health issues led to Rx contraindications. The cat received 4 VetEase treatments over 2 weeks.
13-year-old Pomeranian status post total mastectomy complicated by flap necrosis during recovery. The dog received 6 VetEase treatments over 4 weeks.
Female draft horse presenting with a traumatic abrasion to the hind limb and persistent local irritation. The patient received 6 VetEase treatments over 3 weeks.
Ready to Learn More?
See VetEase in action
Schedule a demo to learn how VetEase and VexoHeal may fit into your practice’s approach to derm and wound cases.
Research & Publications
Preliminary clinical evaluation of the treatment efficacy of a temperature adjustable cryotherapy device for chronic, recurrent blepharitis in dogs.
Effect of localized cryotherapy on interdigital pruritus of dogs with canine atopic dermatitis
Picoliter ice particles by supersonic cryogenic jets for transdermal drug delivery: Extracellular vesicle application for skin diseases
Reference Library: Exosomes, ECVs, and Tissue Repair
Efficacy of Allogeneic and Xenogeneic Exosomes for the Treatment of Canine Atopic Dermatitis: A Pilot Study
Extracellular Vesicles in Skin Wound Healing